Echoes of a failure: what lessons can we learn?

被引:15
作者
Sondak, Vernon K. [1 ]
Khushalani, Nikhil I.
机构
[1] Univ S Florida, Dept Cutaneous Oncol, Moffitt Canc Ctr, Tampa, FL 33612 USA
关键词
STATISTICAL CONTROVERSIES;
D O I
10.1016/S1470-2045(19)30312-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1037 / 1039
页数:4
相关论文
共 6 条
[1]   Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts [J].
Boonstra, P. S. ;
Braun, T. M. ;
Taylor, J. M. G. ;
Kidwell, K. M. ;
Bellile, E. L. ;
Daignault, S. ;
Zhao, L. ;
Griffith, K. A. ;
Lawrence, T. S. ;
Kalemkerian, G. P. ;
Schipper, M. J. .
ANNALS OF ONCOLOGY, 2017, 28 (07) :1427-1435
[2]   Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial [J].
Lesaffre, E. ;
Edelman, M. J. ;
Hanna, N. H. ;
Park, K. ;
Thatcher, N. ;
Willemsen, S. ;
Gaschler-Markefski, B. ;
Kaiser, R. ;
Manegold, C. .
ANNALS OF ONCOLOGY, 2017, 28 (07) :1419-1426
[3]   Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study [J].
Long, Georgina, V ;
Dummer, Reinhard ;
Humid, Omid ;
Gajewski, Thomas F. ;
Caglevic, Christian ;
Dalle, Stephan ;
Arance, Ana ;
Carlino, Matteo S. ;
Grob, Jean-Jacques ;
Kim, Tae Min ;
Demidov, Lev ;
Robert, Caroline ;
Larkin, James ;
Anderson, James R. ;
Maleski, Janet ;
Jones, Mark ;
Diede, Scott J. ;
Mitchell, Tara C. .
LANCET ONCOLOGY, 2019, 20 (08) :1083-1097
[4]   Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037) [J].
Mitchell, Tara C. ;
Hamid, Omid ;
Smith, David C. ;
Bauer, Todd M. ;
Wasser, Jeffrey S. ;
Olszanski, Anthony J. ;
Luke, Jason J. ;
Balmanoukian, Ani S. ;
Schmidt, Emmett V. ;
Zhao, Yufan ;
Gong, Xiaohua ;
Maleski, Janet ;
Leopold, Lance ;
Gajewski, Thomas F. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (32) :3223-+
[5]   Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma [J].
O'Day, Steven J. ;
Eggermont, Alexander M. M. ;
Chiarion-Sileni, Vanna ;
Kefford, Richard ;
Grob, Jean Jacques ;
Mortier, Laurent ;
Robert, Caroline ;
Schachter, Jacob ;
Testori, Alessandro ;
Mackiewicz, Jacek ;
Friedlander, Philip ;
Garbe, Claus ;
Ugurel, Selma ;
Collichio, Frances ;
Guo, Wei ;
Lufkin, Joelle ;
Bahcall, Safi ;
Vukovic, Vojo ;
Hauschild, Axel .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (09) :1211-1218
[6]   Innovation in oncology clinical trial design [J].
Verweij, J. ;
Hendriks, H. R. ;
Zwierzina, H. ;
Hanauske ;
Wacheck, V. ;
Collignon, O. ;
Bruzzi, P. ;
Gross, J. ;
Riehl, T. ;
Bretz, F. ;
Dollins ;
Radtke, I. .
CANCER TREATMENT REVIEWS, 2019, 74 :15-20